DEA Approves Syndros® Cannabis Oral Solution as Schedule II
By William Stash Jones Oregon Cannabis Connection. March 23, 2017— A new pharmaceutical drug produced by the company Insys has
Read moreBy William Stash Jones Oregon Cannabis Connection. March 23, 2017— A new pharmaceutical drug produced by the company Insys has
Read more